John A. Goldman

1.5k total citations
40 papers, 1.0k citations indexed

About

John A. Goldman is a scholar working on Rheumatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John A. Goldman has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 9 papers in Epidemiology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John A. Goldman's work include Systemic Lupus Erythematosus Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). John A. Goldman is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). John A. Goldman collaborates with scholars based in United States, Australia and Canada. John A. Goldman's co-authors include Leon Goldman, Robert G. Meyer, J.A. Gray, Bernard S. Goldman, Stephen B. Miller, John H. Gilliam, Elizabeth W. Karlson, Salah M. Nasrallah, Frederick Wolfe and Eliza F. Chakravarty and has published in prestigious journals such as Nature, New England Journal of Medicine and JAMA.

In The Last Decade

John A. Goldman

40 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Goldman United States 19 299 296 177 133 108 40 1.0k
M F Kahn France 19 432 1.4× 215 0.7× 297 1.7× 236 1.8× 146 1.4× 51 1.2k
G R Struthers United Kingdom 15 348 1.2× 95 0.3× 181 1.0× 105 0.8× 65 0.6× 27 734
Folke D. Lindström Sweden 19 297 1.0× 187 0.6× 135 0.8× 345 2.6× 149 1.4× 55 1.5k
C Cervini Italy 22 990 3.3× 134 0.5× 507 2.9× 113 0.8× 126 1.2× 71 1.7k
A J Crisp United Kingdom 18 402 1.3× 81 0.3× 241 1.4× 208 1.6× 255 2.4× 62 1.5k
Thomas Kinsella Canada 15 475 1.6× 203 0.7× 61 0.3× 305 2.3× 191 1.8× 40 1.1k
A J Wysenbeek Israel 19 452 1.5× 49 0.2× 134 0.8× 219 1.6× 76 0.7× 44 866
Athina Pyrpasopoulou Greece 20 247 0.8× 101 0.3× 78 0.4× 137 1.0× 174 1.6× 65 1.2k
M Ben-Bassat Israel 20 245 0.8× 217 0.7× 209 1.2× 285 2.1× 142 1.3× 73 1.2k
T Egeland Norway 24 225 0.8× 218 0.7× 247 1.4× 574 4.3× 117 1.1× 53 1.8k

Countries citing papers authored by John A. Goldman

Since Specialization
Citations

This map shows the geographic impact of John A. Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Goldman more than expected).

Fields of papers citing papers by John A. Goldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Goldman. The network helps show where John A. Goldman may publish in the future.

Co-authorship network of co-authors of John A. Goldman

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Goldman. A scholar is included among the top collaborators of John A. Goldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Goldman. John A. Goldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldman, John A., et al.. (2021). Severe Skin Infections Due to Serratia marcescens. Infectious Diseases in Clinical Practice. 29(3). e146–e150. 5 indexed citations
2.
Goldman, John A., et al.. (2016). The Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus. The Open Rheumatology Journal. 10(1). 71–80. 11 indexed citations
3.
Fleischmann, Roy, John A. Goldman, Marjatta Leirisalo‐Repo, et al.. (2014). Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study. Current Medical Research and Opinion. 30(11). 2139–2149. 12 indexed citations
4.
Goldman, John A.. (2012). Brand versus Generic Drugs: Should We Be Cautious?. Cureus. 1 indexed citations
5.
Wolfe, Frederick, Michelle Petri, Graciela S. Alarcón, et al.. (2008). Fibromyalgia, Systemic Lupus Erythematosus (SLE), and Evaluation of SLE Activity. The Journal of Rheumatology. 36(1). 82–88. 75 indexed citations
6.
Goldman, John A., H. Amy Xia, Barbara White, & Harold E. Paulus. (2006). Evaluation of a modified ACR20 scoring system in patients with rheumatoid arthritis receiving treatment with etanercept. Annals of the Rheumatic Diseases. 65(12). 1649–1652. 11 indexed citations
7.
Gibofsky, Allan, William Palmer, John A. Goldman, et al.. (2005). Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study. Current Medical Research and Opinion. 22(1). 169–183. 37 indexed citations
8.
Goldman, John A.. (2004). The Women's Health Initiative 2004 - Review and Critique. PubMed Central. 6(3). 6 indexed citations
9.
Goldman, John A., et al.. (1995). Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice. Journal of Clinical Epidemiology. 48(4). 571–582. 44 indexed citations
10.
Goldman, John A.. (1991). Hypermobility and Deconditioning: Important Links to Fibromyalgia/Fibrositis. Southern Medical Journal. 84(10). 1192–1196. 26 indexed citations
11.
Goldman, John A., et al.. (1991). Concise Communications. Arthritis & Rheumatism. 34(9). 1207–1208. 36 indexed citations
12.
Kaluzny, A D, Taylor H. Ricketts, Richard B. Warnecke, et al.. (1989). Evaluating Organizational Design To Assure Technology Transfer: The Case of the Community Clinical Oncology Program. JNCI Journal of the National Cancer Institute. 81(22). 1717–1725. 35 indexed citations
13.
McDougal, J. Steven, Marjorie Hubbard, Frederic C. McDuffie, et al.. (1982). COMPARISON of five assays for immune complexes in the RHEUMATIC DISEASES. An Assessment of Their Validity for Rheumatoid Arthritis. Arthritis & Rheumatism. 25(10). 1156–1166. 27 indexed citations
14.
15.
Goldman, John A., et al.. (1979). Limited plasmapheresis in rheumatoid arthritis with vasculitis. Arthritis & Rheumatism. 22(10). 1146–1150. 51 indexed citations
16.
Goldman, John A., et al.. (1979). Pseudopodagra from Hemophilus Influenza in an Adult. Arthritis & Rheumatism. 22(6). 681–683. 2 indexed citations
17.
Goldman, John A.. (1977). Pseudo-Sjögren Syndrome With Hyperlipoproteinemia. JAMA. 237(15). 1582–1582. 19 indexed citations
18.
Goldman, John A., et al.. (1965). Fiber Optics in Medicine. New England Journal of Medicine. 273(26). 1425–1426. 5 indexed citations
19.
Goldman, John A., et al.. (1965). Fiber Optics in Medicine. New England Journal of Medicine. 273(27). 1477–1480. 8 indexed citations
20.
Goldman, John A. & Robert G. Meyer. (1965). Transmission of Laser Beams through Various Transparent Rods for Biomedical Applications. Nature. 205(4974). 892–894. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M F Kahn Breakdown of academic impact, for papers by G R Struthers Breakdown of academic impact, for papers by Folke D. Lindström Breakdown of academic impact, for papers by C Cervini Breakdown of academic impact, for papers by A J Crisp Breakdown of academic impact, for papers by Thomas Kinsella Breakdown of academic impact, for papers by A J Wysenbeek Breakdown of academic impact, for papers by Athina Pyrpasopoulou Breakdown of academic impact, for papers by M Ben-Bassat Breakdown of academic impact, for papers by T Egeland
Rankless by CCL
2026